UHPLC of Biomarkers Related to Tobacco Smoke Exposure

contributed by YMC | 08/02/2022

In smoking cessation studies, the levels of several biomarkers are considered in order to evaluate the people’s exposure to tobacco smoke. The well-known nicotine is typically considered as one of these biomarkers, but it has a half-life of only two hours in the human body. It is therefore not appropriate for the determination of tobacco smoke exposure after several hours or even days. Cotinine is the main metabolite of nicotine and has a half- life of about eighteen hours. Due to its higher stability, it is one of the widely investigated biomarkers related to tobacco products. However, when patients undergo smoking cessation and replace nicotine with nicotine gums and patches, their cotinine levels are the same as smokers.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.